Search

Introduction: In recent decades, the incidence and mortality rate of brain tumours, especially in adults, has increased. In order to better plan to reduce the burden of this cancer, knowledge of the epidemiological aspects of this disease is essential. Therefore, due to the lack of a comprehensive study on brain cancer in Iran, this study aimed to investigate the epidemiological aspects of this cancer in Iran. Methods: In June 2020, keywords of 'brain tumour', 'nervous system tumours', 'nervous system neoplasm', 'nervous system cancer', 'central nervous system (CNS)' and 'Iran' were searched on Medline/PubMed and Web of Science databases Scopus, Embase, SID, IranMedex, and Google Scholar. The search results were entered Endnotes Version 8; finally, 35 full papers were reviewed and included in the study. Results: The incidence of brain cancer and CNS tumour is lower in children in central Iran. The incidence of CNS cancer was relatively high among children in Golestan province. Furthermore, the standardised incidence of primary CNS tumours in Iran is 5.69 per 100,000, which is lower than in other countries. Nervous system malignancies were more common in men than in women (age-standardized rate 3 versus 2.2 per 100,000 in men and women, respectively). Tehran had the highest incidence of CNS tumours. Meningiomas were the only most common tumour in women. Gliomas were the most common primary brain tumour, and most of the lesions in this subgroup were in low-grade astrocytoma and ependymomas. Brain cancer mortality was higher in men than in women. Age is a potential risk factor, and the incidence of CNS tumours increases with increasing age after 30 years. Conclusion: Nervous system cancers are on the rise in Iran due to lifestyle changes and increased risk factors. Planning to reduce risk factors and early detection of the disease can be helpful in reducing cases and reducing mortality. [ABSTRACT FROM AUTHOR]

Background: Apparent diffusion coefficient (ADC) statistics can be valuable in distinguishing three types of brain tumors. The aim is to evaluate the capability of volume under the receiver operating characteristic (ROC) surface (VUS) for concurrent differential diagnosis of glioblastoma (GBM), lymphoma (LYM), and metastatic tumor(s) (MTTs) lesions of brain malignancies. Methods: Investigated Magnetic Resonance Imaging (MRI) included 57 GBM, 25 LYM, and 25 MTT that were pathological diagnoses, after MR imaging. Region of interest (ROI) was taken from tumor regions (TUMOR), enhancement area (ENHANCED), and peritumoral edema (EDEM) regions. ADC maps were obtained after selecting a region of interest, and First-Order Histogram Features (FOHs) were extracted. Statistical analysis was performed by MedCalc version 15.8 for comparison of continuous variables between three groups of lesions and plotting the ROC curves. For VUS and correct classification rates (CCR) calculations the R software v2.13.1 with the DiagTest3grp package was used. The confidence interval level was 95% for significant results. Diagnostic accuracy of ADC in the differentiation of mentioned three groups was performed using ROC surface. Results: ADCMin, ADC75 and ADC95 Percentile values in TUMOR groups of ROI, ADCMaximum, ADCMin, ADCMean, ADCMedian, ADCUniformity and ADCEntropy in ENHANCED and ADC25, ADC75, ADC95 Percentiles, ADCMean, ADCNormal Mean, ADCMedian, ADCEntropy, ADCThird Moment and ADCStandardDeviation in EDEM had significant VUS values results among GBM, LYM and MTTs. Conclusion: VUS analysis is a helpful statistical method for categorizing types of brain tumors. Using the application of FOHs and proposed cut-off points for them by the VUS analysis, the differentiation of more than two types of brain tumors would be possible, concurrently. This will help neurologists and neurosurgeons to plan their treatment and surgery or monitor the status of patients' therapeutic needs. [ABSTRACT FROM AUTHOR]

Background: Changes in the body fluid and serum electrolyte status following major operations, such as brain tumor resection, are always expected. These changes can increase post-operation morbidity and mortality. Objectives: We aimed to evaluate the changes in serum electrolyte levels and renal function parameters in brain tumor patients after operation. Materials & Methods: This cross-sectional study was performed on 168 patients with supratentorial tumors in Poursina Hospital, Rasht City, Iran, in 2020. The study parameters included patients' demographics, hemodynamic stability, serum sodium, potassium, blood urea nitrogen (BUN) and creatinine levels, urine specific gravity, and urinary output, measured immediately and 12 hours after the operation. Results: This study revealed statistically significant increases in serum sodium level (from 139.70±5.60 meq/L to 140.34±6.23 meq/L, P=0.002), urinary output (from 1043.70±455.00 mL to 1967.50±661.10 mL, P=0.008), urine specific gravity (from 1.010±0.007 to 1.012±0.008, P=0.011), and in serum BUN level (from 17.46±6.92 to 18.41±6.40, P=0.001), but significant decrease in serum potassium level (from 3.88±0.49 meq/L to 3.78±0.28 meq/L, P=0.017) during the first 12 hours after operation. However, the change in serum creatinine level was not significant (from 1.18±2.08 mg/dL to 1.17±2.08 mg/dL, P=0.787). Conclusion: Significant changes in serum electrolytes (sodium and potassium) and renal function indicators (urine output, specific gravity, and serum BUN) are expected within the first 12 hours after brain tumor operation. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Guilan University of Medical Sciences is the property of Journal of Guilan University of Medical Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: The current study aimed to determine the trends in esophageal cancer (EC) patients and examine the impact of the type and anatomical location of the tumor and the site of metastasis on their survival. Method: In this retrospective cohort study, we investigated 305 patients with a definite diagnoses of EC, who had been hospitalized at the Mahdie Hospital of Hamadan, Iran, during ten years from 2005-2015. EC-related survival considering different types and locations of the tumor, as well as the sites of metastasis, was evaluated. Survival was calculated using Kaplan-Meier curves and a multivariable Cox regression analysis (MVA) was performed. Results: Squamous cell carcinoma was found in 76.6% of the patients and 23.4% had adenocarcinoma (AC). There was a significant relationship between the location and pathological type of tumor; 87% of ACs happened in the lower part of the esophagus (P = 0.015). The 1- to 5-year relative survival of the patients was 46%, 25%, 22%, 12%, and 7%, respectively. The rate of death in liver, lung, brain, pancreas, abdomen, and lymph nodes metastasis were respectively 42.9%, 21.4%, 14.3%, 7.1%, 7.1%, and 7.1%. No significant relationships were observed between the tumor type and metastasis (P = 0.14) or between the tumor type and the location of metastasis (P = 0.7). Conclusion: Similar to other reports, the rate of survival was higher in AC type, yet the rate of total survival in Iran was much lower than that in developed countries. There were no differences in the survival rate concerning the location of the tumor. The obtained results did not show any relationships among the tumor type, the location of metastasis, and the total survival. [ABSTRACT FROM AUTHOR]